Jose Cevallos Yepez, MD
Internal Medicine · Cape Coral, FLNPI 1922236736
Payments from drug & device makers
Across 1,184 payments — averaging $3575.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$924K
- Eli Lilly$799K
- Avanir Pharmaceuticals, Inc.$790K
- Novartis$421K
- Pfizer$357K
- Novo Nordisk AS$350K
- plus $593K from 19 others
Across 7 payments — averaging $3393.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$24K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 356 | $924,485 |
| Eli Lilly | 12 | $798,685 |
| Avanir Pharmaceuticals, Inc. | 172 | $789,930 |
| Novartis | 25 | $420,866 |
| Pfizer | 37 | $356,620 |
| Novo Nordisk AS | 65 | $349,685 |
| Esperion Therapeutics, Inc. | 336 | $176,424 |
| Ferring International Pharmascience Center US | 58 | $169,264 |
| Chiesi USA, Inc. | 50 | $116,195 |
| Ferring Pharmaceuticals AS | 21 | $77,676 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $41,341 |
| AbbVie(2 entities) | 8 | $10,948 |
| Teva Pharmaceuticals USA, Inc. | 6 | $409 |
| Johnson & Johnson | 9 | $135 |
| Novo Nordisk | 5 | $77 |
| Boehringer Ingelheim | 4 | $60 |
| GSK | 4 | $60 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $46 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $33 |
| Sunovion Pharmaceuticals Inc. | 2 | $32 |
| AstraZeneca | 2 | $32 |
| Genentech, Inc. | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
How this compares
$4,233,104 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Cape Coral
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
- Nelia Sanchez-CrespoHollywood$28.8M
- Kwabena AyesuOrlando$27.6M
- Michael DeverWindermere$24M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.